Rapid Pathogen Detection
Rapid Pathogen Detection - Related Videos
09:04
Foodborne Pathogen Screening Using Magneto-fluorescent Nanosensor: Rapid Detection of E. Coli O157:H7
0 Views •
Cited by 14 •
2017
The overall goal of this protocol is to synthesize functional nanosensors for the portable, cost-effective, and rapid detection of specifically targeted pathogenic bacteria through a combination of magnetic relaxation and fluorescence emission modalities.
09:10
Combination of Adhesive-tape-based Sampling and Fluorescence in situ Hybridization for Rapid Detection of Salmonella on Fresh Produce
0 Views •
Cited by 17 •
2010
This protocol describes a simple adhesive-tape-based approach for sampling of tomato and other fresh produce surfaces, followed by rapid whole cell detection of Salmonella using fluorescence in situ hybridization (FISH).
01:25
Rapid Identification of Pathogens
0 Views •
2026
MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
12:54
Detection of Foodborne Bacterial Pathogens from Individual Filth Flies
0 Views •
Cited by 20 •
2015
A PCR-based protocol was adapted to detect Cronobacter spp., Salmonella enterica, and Listeria monocytogenes from body surfaces and alimentary canals of individual wild-caught flies. The goal of this protocol is to detect and isolate bacterial pathogens from individual insects collected as part of an environmental sampling program during foodborne outbreak investigations.
07:16
Rapid Point-of-Care Detection of Pathogens for Lower Respiratory Tract Infections in ICU Patients
0 Views •
2026
This protocol describes a fully integrated microfluidic chip-based LAMP method enabling point-of-care detection of 15 pathogens causing lower respiratory tract infections in ICU patients within one hour.
FAQs
These methods focus on different biological signals. Nucleic-acid approaches identify pathogen genetic material, while antigen-based methods recognize pathogen proteins. Immune-response assays instead measure host reactions associated with infection. This distinction affects what the test reveals: direct pathogen markers can support identification of the microorganism, whereas immune signals provide information about the host-pathogen interaction.
Analytical sensitivity determines how effectively a method can detect pathogen material or related biological markers, particularly when the available signal is limited. Combining high sensitivity with rapid processing can support earlier recognition than conventional culture-based testing. This is especially relevant for pathogens that are difficult to grow, because delayed or unsuccessful culture may slow diagnostic and infection-control decisions.
Molecular amplification increases the detectable signal from pathogen-specific nucleic acids. Antigen recognition uses selective binding to identify pathogen proteins, while biosensors convert biological recognition into a measurable signal. Although these mechanisms differ, each links a pathogen-associated target to an observable result, allowing investigators to select an approach suited to the sample and the biological information required.
A typical application begins with obtaining a clinical or environmental sample, selecting a pathogen-associated target, and applying a method based on nucleic-acid detection, antigen recognition, immune-response measurement, or biosensor signaling. The resulting signal is then interpreted in relation to infection or contamination. The workflow is designed to provide useful information sooner than conventional culture-based testing.
It is useful when investigators need timely information about infectious microorganisms, biological markers, or host responses. In immunology and infection research, the results can help characterize host-pathogen interactions and assess treatment responses. Faster access to these data supports studies in which changes in infection status or immune behavior must be recognized without waiting for slower culture-based results.
Earlier detection can provide information that informs antimicrobial decisions and helps identify patterns during outbreak investigations. It also supports infection-control efforts by enabling more timely recognition of infectious threats. In surveillance settings, rapid results can contribute to tracking pathogen occurrence, while improved speed and sensitivity may strengthen intervention when conventional culture is slow or pathogens are difficult to grow.